Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in allotransplant immunology.

A John Barrett1, Katayoun Rezvani, Scott Solomon

  • 1Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892-0003, USA.

Hematology. American Society of Hematology. Education Program
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue-Based Transcriptomic Profiling of Gastrointestinal Graft Versus Host Disease Reveals Immune and MicroRNA Dysregulation.

International journal of molecular sciences·2026
Same author

<i>In Vitro</i> MSC Characterization of Cryopreserved Adipose Stromal Cells Processed via Uvence Workflow.

Tissue engineering. Part C, Methods·2026
Same author

Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Blood·2026
Same author

Selective MicroRNA Packaging Reveals Distinct Core Signatures in Human Mesenchymal-Stromal-Cell-Derived Extracellular Vesicles.

International journal of molecular sciences·2025
Same author

Dynamics of neoantigen-specific T-cells in post-transplant relapse: do leukemia neoantigens elicit immune responses in transplant recipients?

Bone marrow transplantation·2025
Same author

The Use of MPS in Three Rs and Regulatory Applications: Perspectives From Developers on Stakeholder Responsibilities.

Alternatives to laboratory animals : ATLA·2025

Allogeneic stem cell transplants can cause graft-versus-host disease (GVHD) and immune dysfunction. New strategies focus on understanding alloimmune interactions and genetic factors to control immune reconstitution and improve transplant outcomes.

Area of Science:

  • Immunology
  • Transplantation Biology
  • Genetics

Background:

  • Allogeneic stem cell transplantation (SCT) offers a graft-versus-malignancy effect but risks graft-versus-host disease (GVHD) and immune dysfunction.
  • Recent advances provide molecular insights into alloimmune interactions and immune recovery post-SCT.

Purpose of the Study:

  • To review current understanding of alloresponses, genetic modifiers, and strategies for controlling immune reconstitution after SCT.
  • To explore methods for separating beneficial graft-versus-leukemia (GVL) effects from detrimental GVHD.
  • To discuss non-pharmaceutical approaches for modulating immune recovery.

Main Methods:

  • Review of cellular and molecular mechanisms of alloresponses, GVHD, and GVL.
  • Analysis of genetic polymorphisms (HLA and non-HLA) influencing immune reconstitution and outcomes.

Related Experiment Videos

  • Description of novel techniques for controlling immune reactions, including T-cell manipulation and suicide gene therapy.

    • Main Results:

    • Leukemia-restricted antigens and NK cell alloreactivity are key to separating GVHD and GVL.
    • Genetic polymorphisms in cytokine genes and minor histocompatibility antigens significantly impact transplant outcomes.
    • Non-pharmaceutical methods show promise in eliminating GVHD while preserving GVL and antiviral immunity.

    Conclusions:

    • Understanding alloimmune interactions and genetic factors is crucial for optimizing SCT.
    • Targeted strategies can potentially separate GVHD from GVL, improving therapeutic efficacy.
    • Advanced T-cell modulation techniques offer new avenues for controlling immune reconstitution and preventing GVHD.